FIRST-ENGOT-Ov44 (ENGOT/GCIG/Tesaro)

A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Contact Person
Status
Closed to Recruitment
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
AGO
GEICO
MITO
ISGO
DGOG
NCRI
CEEGOG
NSGO-CTU
SGCTG
GCIG Number